Accelerating BioVenture Innovation (ABI) is a 15-week, graduate-level course in entrepreneurial training that builds teams around patented technologies from Weill Cornell Medicine and neighboring institutions.

The program educates participants on all aspects of launching a company. Teams create pitch decks based on weekly instruction and mentorship from industry experts, and then finalist teams are selected to pitch to a panel of investor judges.

The pitches will take place on Dec 5 in Uris Auditorium, 1300 York Ave, New York, NY. A networking reception will follow at Griffis Faculty Lounge at the same location.